OncoVerity is a cutting-edge biotech company using a computational biology platform to better the lives of patients battling cancer. OncoVerity is addressing a fundamental challenge in cancer treatment—the diverse nature of cancer cells—by using single-cell analysis technology and machine learning to advance transformative cancer therapies.

EnteroTrack produces EnteroTracker®, a simple-to-use, inexpensive device to sample the upper gastrointestinal (GI) system in children and adults without the need for endoscopy. Screening or monitoring the upper GI tract is important to catch diseases early such as esophageal cancer or to control chronic conditions such as Eosinophilic Esophagitis (EoE).

GelSana engineers highly elastic wound dressing polymers which stretch and conform across any wound, reduce inflammation through polymer chemistry, prevent infection, and provide sustained drug delivery over time.

RheumaGen is a cell and gene therapy company developing therapies with the potential to cure rheumatoid arthritis (RA) and other major autoimmune diseases like multiple sclerosis (MS), juvenile diabetes (T1D), ankylosing spondylitis, and celiac disease.

Vona Oncology: Providing New Hope for Patients with Aggressive Cancers What the Company Does Vona Oncology is an early clinical stage bio-pharmaceutical company developing targeted therapeutics to treat aggressive cancers such as triple-negative breast cancer (TNBC), ovarian cancer, and melanoma. Vona Oncology has an innovative, novel small molecule that is very efficacious with little toxicity to improve standard of care. Current Landscape About 20 percent of women diagnosed with breast cancer are triple negative, which means therapy options with targeted drugs are very limited. TNBC is often diagnosed in younger women, at very advanced stages with high likelihood of relapse...

Atara Biotherapeutics is on a mission to “unleash the natural power of the body’s immune system by harnessing the compelling biological features of T cells—the immune system's most effective weapon in fighting disease.” The Atara site at Fitzsimons Innovation Community is a world-class manufacturing facility with a research and development focus. Atara’s expertise, talent, and track record of firsts elevate Colorado’s presence as a cell and gene therapy hub.